Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Oncternal Therapeutics Inc ONCT

Healthcare Biotechnology
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of oncology therapies for the treatment of patients with cancers that have critical unmet medical needs. The Company’s product candidates include ONCT-534, ONCT-808, Zilovertamab, and ONCT-216. ONCT-534 is a dual-action androgen receptor inhibitor (DAARI), for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ONCT)

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire October 22, 2024

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives

GlobeNewswire September 12, 2024

Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results

GlobeNewswire August 1, 2024

Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire July 15, 2024

Oncternal Therapeutics to Present in JonesTrading Healthcare Summit

GlobeNewswire July 11, 2024

Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire May 30, 2024

Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

GlobeNewswire May 9, 2024

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results

GlobeNewswire May 2, 2024
View More News ››

Opinion & Analysis (NDAQ:ONCT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ONCT)

Oncternal Therapeutics, Inc. (NASDAQ:ONCT): Advancing Novel

http://beyondspx.com/2024/07/31/oncternal-therapeutics-inc-nasdaqonct-advancing-novel-oncology-therapies-with-promising-pipeline/
MikeTester - August 2, 2024

ONCT announced stock split 1-20

Just In: $ONCT ONCT announced stock split 1-202024-01-08 08:02:08 ET Oncternal Therapeutics Inc (ONCT) announced stock split at a ratio...
whytestocks - January 8, 2024

GTX Inc Del Options

On 01/23/09 GTX Inc Del options ( GTXI ) are used as an example of market neutral investing on PERSONALHEDGEFUNDS.COM. Hedge fund...
nickmessaro02 - January 23, 2009
View more Bullboard ››

Lahontan Gold Corp.

Lahontan Gold Corp.

Lahontan Gold Corp. is a Canada-based mineral exploration company. The Company is engaged in the identification, acquisition, ...
View More »